Express Pharma
JANUARY 25, 2025
The Union Budget 2025-26 represents an opportunity for India to recalibrate policies that will drive the pharmaceutical sector forward as it approaches significant economic and industrial growth. India’s pharmaceutical industry is poised for transformative growth thanks to its ability to supply affordable medicines worldwide.
Express Pharma
MARCH 2, 2025
Union Minister of Chemicals and Fertilizers, and Health and Family Welfare, Jagat Prakash Nadda inaugurated the weeklong celebrations of Jan Aushadhi Diwas, 2025 by flagging off the Rath (Chariot) and 10 other vehicles carrying the information about Pradhan Mantri Bhartiya Janaushadhi Pariyojana from Nirman Bhawan. to the citizens.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
OCTOBER 27, 2024
IPA leadership is committed to strengthening operational capabilities and ensuring that patients worldwide have access to affordable and quality-assured medicines.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.
pharmaphorum
OCTOBER 6, 2022
Fresh with a new brand identity, the France-headquartered pharma group has pledged to grow its oncology sales from its current objective of €1 billion in 2025 to €3 billion in 2030, continuing a diversification of its business from its traditional focus on cardiovascular diseases. billion and $1.8 billion, respectively, five years later.
Express Pharma
JULY 3, 2023
India is known as the ‘Pharmacy of the World’, as the generic medicine supplier for over 200 countries, both developed and emerging markets. A large presence of local players producing branded generics, along with lower price levels, has provided India with a unique opportunity. How poised are you to leverage them?
European Pharmaceutical Review
FEBRUARY 3, 2025
EMAs human medicines committee (CHMP) recommended eight medicines for EU marketing authorisation at its January 2025 meeting. Additionally, the CHMP recommended the generic medicine Eltrombopag Accord (eltrombopag) to treat primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C.
Express Pharma
APRIL 2, 2025
US President Donald Trump announced new tariffs on April 2, 2025, as part of his Liberation Day economic plan. healthcare by ensuring a steady supply of affordable medicines. The decision underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability, and national security.
Expert insights. Personalized for you.
76 
Let's personalize your content